Mesnard Floor Amendment
Reference to: FINANCE Committee amendment
Amendment drafted by: Leg Council
FLOOR AMENDMENT EXPLANATION
1. Changes the AB-rated generic equivalent in the Finance Committee amendment to a generic equivalent.
2. Defines a generic equivalent.
3. Removes the option of a clinical pathway that is contained in the Finance Committee amendment.
First Regular Session H.B. 2166
MESNARD FLOOR AMENDMENT
SENATE AMENDMENTS TO H.B. 2166
(Reference to FINANCE Committee amendment)
Page 1, before line 1, insert:
"Page 1, line 5, strike "definition" insert "definitions""
Lines 3 and 4, strike "an AB‑rated" insert "a"
Strike line 8
Reletter to conform
Between lines 9 and 10, insert:
"Line 12, strike the comma insert ":
1. "Generic equivalent":
(a) Means a drug that has an identical amount of the same active chemical ingredients in the same dosage form, that meets applicable standards of strength, quality and purity according to the United States pharmacopeia or other nationally recognized compendium and that, if administered in the same amounts, will provide comparable therapeutic effects.
(b) Does not include a drug that is listed by the United States food and drug administration as having unresolved bioequivalence concerns according to the administration's most recent publication of approved drug products with therapeutic equivalence evaluations.
2.""
Amend title to conform
